Aurlumyn Side Effects
Generic name: iloprost
Medically reviewed by Drugs.com. Last updated on May 20, 2024.
Note: This document provides detailed information about Aurlumyn Side Effects associated with iloprost. Some dosage forms listed on this page may not apply specifically to the brand name Aurlumyn.
Applies to iloprost: inhalation solution.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly.
This medicine may cause your blood pressure to go down. Your doctor will check your blood pressure before you start the medicine and may check it during your regular office visits. You may also need to monitor your blood pressure at home. If you notice any changes to your recommended blood pressure, call your doctor right away.
Dizziness, lightheadedness, or fainting may occur after you use this medicine, especially when you get up suddenly from a lying or sitting position. Getting up slowly may help, but if the problem continues or gets worse, check with your doctor. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or lightheaded.
Check with your doctor right away if you have chest pain, difficult, fast, or noisy breathing, sometimes with wheezing, blue lips and fingernails, pale skin, increased sweating, coughing that sometimes produces a pink frothy sputum, shortness of breath, or swelling in the legs and ankles. These may be signs of pulmonary edema (fluid in the lungs).
Tell your doctor if you are pregnant or plan to become pregnant before using this medicine.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Common side effects of Aurlumyn
Some side effects of iloprost may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
Less common side effects
- change in taste
- mouth irritation
- tongue irritation or pain
Incidence not known
- nosebleeds
- stuffy nose
Serious side effects of Aurlumyn
Along with its needed effects, iloprost (the active ingredient contained in Aurlumyn) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking iloprost:
Incidence not known
- black, tarry stools
- chest pain
- cough
- difficult or labored breathing
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- extreme fatigue
- fast, pounding, or irregular heartbeat or pulse
- fever
- hives, itching, or rash
- irregular breathing
- noisy breathing
- pinpoint red spots on the skin
- swelling of the eyelids, face, lips, fingers, feet, or lower legs
- tightness in the chest
- troubled breathing or swallowing
- unusual bleeding or bruising
For healthcare professionals
Applies to iloprost: inhalation solution, intravenous solution.
General adverse events
The most frequently reported side effects were vasodilation (flushing), cough increased, headache, trismus, insomnia, nausea, hypotension, vomiting, alkaline phosphatase increased, flu syndrome, back pain, tongue pain, palpitations, syncope, GGT increased, muscle cramps, hemoptysis, and pneumonia.[Ref]
Cardiovascular
- Very common (10% or more): Vasodilation/flushing (up to 27%), hypotension (up to 11%)
- Common (1% to 10%): Tachycardia, palpitation
- Frequency not reported: Congestive heart failure, supraventricular tachycardia[Ref]
Gastrointestinal
- Very common (10% or more): Nausea (up to 13%)
- Common (1% to 10%): Diarrhea, vomiting, mouth/tongue irritation, mouth/tongue pain
- Frequency not reported: Dysgeusia[Ref]
Nervous system
- Very common (10% or more): Headache (up to 30%)
- Common (1% to 10%): Dizziness, syncope[Ref]
Respiratory
- Very common (10% or more): Cough increased (up to 39%), epistaxis, hemoptysis
- Common (1% to 10%): Dyspnea, pharyngolaryngeal pain, throat irritation, pneumonia
- Frequency not reported: Bronchospasm, wheezing
- Postmarketing reports: Nasal congestion[Ref]
Musculoskeletal
- Very common (10% or more): Pain in jaw/trismus (up to 12%)
- Common (1% to 10%): Back pain, muscle cramps[Ref]
Renal
- Frequency not reported: Kidney failure[Ref]
Other
- Very common (10% or more): Flu-like syndrome (14%), peripheral edema (up to 12.2%), chest discomfort/chest pain
- Common (1% to 10%): Alkaline phosphatase increased, GGT increased[Ref]
Dermatologic
- Common (1% to 10%): Rash[Ref]
Hematologic
- Very common (10% or more): Bleeding events
- Frequency not reported: Thrombocytopenia[Ref]
Immunologic
- Frequency not reported: Hypersensitivity[Ref]
Psychiatric
- Common (1% to 10%): Insomnia[Ref]
See also:
References
1. (2005) "Product Information. Ventavis (iloprost)." Actelion Pharmaceuticals US Inc
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
More about Aurlumyn (iloprost)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Breastfeeding
Patient resources
Other brands
Professional resources
- Aurlumyn prescribing information
- Iloprost (Pulmonary Hypertension)(Oral Inhalation) (AHFS Monograph)
Other brands
Related treatment guides
Further information
Aurlumyn side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.